The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective ...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the appointment of Melanie ...

Once determined to be safe and effective, their clearances open up new regulatory pathways for other developers of future systems ... cartridge for continuous renal replacement therapy developed ...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the appointment of Thomas ...

These forward-looking statements involve risks and uncertainties regarding the operations and future results ... for use during continuous renal replacement therapy. We believe this profile ...

SeaStar Medical Fourth Quarter and Year-End 2024 Financial Results Conference Call Thursday, March 27, at 4:30 p.m. ET / 1:30 p.m. PT A replay of the call will be available after 7:30 pm ET and can be ...

Altogether, the wide-ranging possibilities of advanced therapy medicinal products (ATMPs) could make therapeutic treatment of these incurable diseases possible in the near future ... functional ...

Renal replacement therapy (RRT) is a life-saving treatment for patients with impaired kidney function, which affects their ability to flush and store fluids. In situations where the kidneys are ...